The military health system's main pipeline for gloves, dressings, instruments and other everyday medical supplies is moving to a new set of distributors, and Cardinal Health appears set to carry most of the load. The Defense Logistics Agency's Medical Surgical Prime Vendor program produced awards to Cardinal Health, McKesson Medical-Surgical Government Solutions and Concordance Healthcare Solutions with a combined potential value of more than $3.7 billion, according to yourNEWS's Oct. 28 report on the Department of War's daily contract announcement.
The primary announcement, which GlobalSecurity mirrors, was not retrievable when GovConFeed prepared this article, so the figures below come from yourNEWS's summary of it. That summary does not break down the awards by contract number, region or customer group, and GovConFeed has not independently confirmed how many separate contracts were issued.
How the $3.7 Billion Splits Among Three Distributors
yourNEWS described the package this way: "Cardinal Health received the largest individual awards, including contracts valued at approximately $1.5 billion and $1.12 billion, while McKesson received a contract worth about $741.5 million." The outlet put the combined potential value of the three firms' contracts at "more than $3.7 billion."
By GovConFeed's arithmetic, the two Cardinal awards named in that report add up to roughly $2.62 billion, which is about 71 percent of a $3.7 billion total. McKesson's $741.5 million is about 20 percent. The remaining amount, on the order of $340 million or less than 10 percent of the total, would cover Concordance's contracts and any other Cardinal awards the summary does not itemize. Because the report calls Cardinal's two contracts "including" the largest awards, Cardinal's full share could be somewhat higher than the $2.62 billion computed here.
These are potential values on indefinite-delivery vehicles, not guaranteed spending. Actual obligations depend on what military hospitals and clinics order over the life of each contract. That is how IDIQ contracts generally work: the government commits to a minimum and the ceiling represents the most it expects to buy.
Who Buys Through the Medical Surgical Prime Vendor Program?
The customer list extends well beyond the Defense Department. According to yourNEWS, the contracts "will support the Army, Navy, Air Force, Marine Corps, Defense Health Agency, Department of Veterans Affairs and Department of Health and Human Services." That mix makes the program one of the larger cross-agency channels for commercial medical supplies in the federal government.
The prime vendor model gives each medical treatment facility a single distributor for routine orders. HigherGov's profile of the predecessor vehicle describes the setup: the program "has established three Global regions (North, South, and West), including primary and backup support," and the prime vendor is "the primary distribution channel (single distributor) for procurement and delivery of a full range of commercial medical/surgical supplies to a group of Medical Treatment Facilities (MTFs) in the geographical regions."
The same profile lists the supply classes the vehicle can cover, including drugs and biologicals, surgical dressing materials, medical and surgical instruments, hospital and surgical clothing, and safety and rescue equipment. It also notes that "A Medical Air Bridge and Prime Vendor War Readiness support is also provided," a reminder that the program supports contingency operations as well as day-to-day hospital stocking. Those descriptions apply to MSPV V, and GovConFeed has not seen the new contracts' statements of work, so the new vehicles' scope may differ in detail.
Base Period, Options and the December 2029 Ordering Date
The contract structure leaves room for a long relationship. yourNEWS reports that "the medical supply contracts include a base period of two years and six months, with additional option periods, while the current ordering period runs through December 6, 2029." The report does not say how many option periods exist or how long each runs, so the total potential duration of the new awards is not established by the sources GovConFeed could read.
The ordering end date is the practical marker for contractors. Anything beyond it would depend on DLA exercising options, and distributors planning inventory, pricing and staffing commitments should treat the base period as the firm window and everything after as contingent.
The Handoff From MSPV V Before August 2027
The new awards follow the current generation of the program. According to HigherGov's vehicle record, "Medical Surgical Prime Vendor V (MSPV V) awarded by DLA Troop Support - Medical in April 2021 accepts orders through August 2027." HigherGov lists the ordering period end date as Aug. 27, 2027, and shows about $1.56 billion obligated through the vehicle to date.
That date sets the likely transition window. If the new contracts are already in place, the legacy vehicle can keep taking orders for roughly another 10 months. Moving hundreds of medical facilities from one distribution arrangement to another typically involves catalog mapping, pricing agreements with manufacturers, warehouse positioning and ordering-system changes, so an overlap would give DLA and its customers time to shift volume without a gap in supply. None of the sources GovConFeed read describes a transition schedule or says which facilities will move first, so how the handoff will be sequenced remains unknown.
One comparison is worth noting. HigherGov reports that MSPV V has no ceiling and about $1.56 billion obligated since 2021, while the new awards carry a combined potential value above $3.7 billion. The two figures measure different things, since one is actual obligations and the other is potential value, so they should not be read as a forecast of higher spending.
What It Means for Contractors
For the three winners, the awards lock in a large share of federal medical-supply volume for at least the base period. Cardinal's awards, at roughly $2.6 billion or more in combined potential value by the reported figures, make it the dominant distributor in the program's next phase. McKesson's roughly $741.5 million award keeps it inside the program, and Concordance, a smaller distributor, gains a federal foothold alongside two of the country's largest health care supply companies.
For medical device and supply manufacturers, the award matters as much as it does for distributors. Prime vendor programs shape which products reach military and VA facilities, so manufacturers that sell through government channels will want distribution relationships with Cardinal, McKesson or Concordance to keep their products moving once MSPV V stops accepting orders in August 2027.
For firms that bid and did not win, the usual options apply: request a debriefing, weigh whether a bid protest is warranted, or pursue subcontracting and supply roles under the three primes. The sources GovConFeed read do not say how many offerors competed or whether any challenge has been filed.
For smaller firms watching DLA medical buys, the practical step is to watch for ordering data under the new contract numbers once they appear in public procurement databases, and to track how quickly volume moves off MSPV V as the August 2027 date approaches.
